Amgen will acquire Rodeo Therapeutics, along with its preclinical program focused on the development of potential therapies for inflammatory…
Articles by Marisa Wexler, MS
The key topics of discussion during a new webinar for people with pulmonary fibrosis (PF) focused on strategies —…
People should be reimbursed for costs of using Ofev (nintedanib) to treat progressive fibrosing interstitial lung diseases (PF-ILD), two…
The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for ImmunoMet Therapeutics‘ treatment…
Severely reduced lung function is not closely related to walking ability in people with idiopathic pulmonary fibrosis (IPF), a…
The Pulmonary Fibrosis Foundation (PFF)Â announced that United Therapeutics will sponsor the PFF Registry. The Registry is a…
A four-year, $2.4 million federal grant given investigators at Boston University School of Medicine (BUSM) will support work to create a…
The Open Source Imaging Consortium (OSIC), a nonprofit collaborative group focused on combatting lung diseases, announced the winners of a…
People with prediabetes or diabetes who live in smog-filled cities may be more prone to pulmonary fibrosis as a result…
The U.S. Food and Drug Administration (FDA) has granted treprostinil orphan drug designation for the treatment of idiopathic pulmonary…